These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5633700)

  • 21. A trial of long-acting sulphonamide R.O. 4-4393 (fanasil) in treatment of cases of lepromatous leprosy with repeated E.N.L.
    Ekambaram V; Venkatachari S
    Lepr India; 1976 Jan; 48(1):24-30. PubMed ID: 1022953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of South American blastomycosis with a new long-acting sulfonamide.
    Lopes CF; Raphael A; Neto VA; Sampaio SA
    Dermatol Int; 1967; 6(4):231-5. PubMed ID: 4877617
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of an ultralong-acting sulphonamide (Fanasil) as a prophylactic agent.
    Stein H; Cohen H; Katze H; Goldberg J
    S Afr Med J; 1972 Sep; 46(38):1370. PubMed ID: 4638225
    [No Abstract]   [Full Text] [Related]  

  • 24. [Errors of sulfonamide therapy in obstetrics].
    Bruniquel G
    Bull Fed Soc Gynecol Obstet Lang Fr; 1971; 23(5):661-2. PubMed ID: 5161962
    [No Abstract]   [Full Text] [Related]  

  • 25. Chemotherapy in Leprosy.
    Leiker DL
    Int J Dermatol; 1975 May; 14(4):254-62. PubMed ID: 1093982
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of a new sulfonamide, sulfametin, in urinary tract infections.
    Chernoff RW; Klein SS
    J New Drugs; 1965; 5(4):225-32. PubMed ID: 5325539
    [No Abstract]   [Full Text] [Related]  

  • 27. A century of progress in the therapy of leprosy.
    Karat AB; Ramanujam K
    Int J Lepr Other Mycobact Dis; 1973; 41(3):382-91. PubMed ID: 4130572
    [No Abstract]   [Full Text] [Related]  

  • 28. Adverse reaction to potentiated sulphonamides in horses?
    Gray A
    Vet Rec; 1989 Aug; 125(6):138. PubMed ID: 2773262
    [No Abstract]   [Full Text] [Related]  

  • 29. [Lyell's syndrome consequent to slow-reacting sulfonamide therapy].
    Gayet R; Chapuis JL
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):529-32. PubMed ID: 4804436
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacokinetic studies with a long-acting sulfonamide in subjects of different ages. A modern approach to drug dosage problems in developmental pharmacology.
    Sereni F; Perletti L; Marubini E; Mars G
    Pediatr Res; 1968 Jan; 2(1):29-37. PubMed ID: 5636244
    [No Abstract]   [Full Text] [Related]  

  • 31. [Severe Lyell's syndrome after taking a single long term sulfonamide imposed at an airport in view of anticholera prophylaxis].
    Vissian L; Lapeyre L; Bauza R; Moulin M; Kermarec J; Duplay H
    Bull Soc Fr Dermatol Syphiligr; 1972; 79(5):475-7. PubMed ID: 4661716
    [No Abstract]   [Full Text] [Related]  

  • 32. [Harnosal- a new middle-time sulfonamide for treatment of urinary tract and kidney infections].
    Ehrlich R
    Z Allgemeinmed; 1971 Jan; 47(1):33-4. PubMed ID: 5547155
    [No Abstract]   [Full Text] [Related]  

  • 33. Activity and effective serum level of repository sulphones (DADDS) in lepromatous leprosy.
    Anand LC; Rathore BS
    Lepr India; 1979 Jul; 51(3):358-62. PubMed ID: 513651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [23 cases of severe bullous toxicoderma with necroepidermolysis. A major risk of delayed-action anti-infective and multiple-drug preparations: Debré-Lamy-Lamotte-Malcar syndrome, later named Lyell's syndrome].
    Huriez C; Bergoend H; Bertez MT
    Rev Fr Allergol; 1972; 12(4):381-7. PubMed ID: 4649619
    [No Abstract]   [Full Text] [Related]  

  • 35. A pilot study of leprosy treatment with a combination of various antileprosy drugs. Preliminary report.
    Blenska W; Kolakowska E
    Z Tropenmed Parasitol; 1973 Dec; 24():Suppl 1:26-31. PubMed ID: 4780895
    [No Abstract]   [Full Text] [Related]  

  • 36. [Ro-4-4393 in the treatment of leprosy. Results after a year of treatment].
    Andrade JC
    Hospital (Rio J); 1966 Aug; 70(2):311-20. PubMed ID: 5300307
    [No Abstract]   [Full Text] [Related]  

  • 37. [Delayed-action sulfonamides: Fanasil. Comprehensive study].
    Leng-Lévy J; David-Chaussé J
    J Med Bord; 1966 May; 143(5):739-44. PubMed ID: 5943724
    [No Abstract]   [Full Text] [Related]  

  • 38. [Considerations on plans for dosage of delayed-action sulfamides].
    Plancher AC; Salvi G; Strata A; Valdrè MV
    Clin Ter; 1967 Feb; 40(4):334-9. PubMed ID: 6077853
    [No Abstract]   [Full Text] [Related]  

  • 39. Repository acedapsone in leprosy chemoprophylaxis and treatment.
    Sloan NR; Worth RM; Jano B; Fasal P; Shepard CC
    Lancet; 1971 Sep; 2(7723):525-6. PubMed ID: 4105668
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of leprosy with 2-sulfanilamido-3-methoxypyrazine (SMPz)].
    Alonso AM
    Rev Bras Med; 1965 May; 22(5):313-20. PubMed ID: 5841420
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.